Cefotaxime susceptibility should not be used to predict ceftriaxone susceptibility among Klebsiella oxytoca clinical isolates

• Andrew Walkty,
• Heather J. Adam,
• James A. Karlowsky,
• David C. Alexander

Affiliations

Andrew Walkty

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada; Section of Infectious Diseases, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Corresponding author. Present address: MS673B, Microbiology, Health Sciences Centre, 820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada.

Heather J. Adam

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada

James A. Karlowsky

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada

David C. Alexander

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada